UBS Group upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLY – Free Report) to a strong-buy rating in a research note released on Wednesday morning, Zacks.com reports.
Separately, JPMorgan Chase & Co. lowered Reckitt Benckiser Group from an overweight rating to a neutral rating in a research report on Thursday, August 29th. One analyst has rated the stock with a sell rating, five have issued a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Reckitt Benckiser Group presently has an average rating of Hold and an average price target of $7,400.00.
Get Our Latest Stock Report on RBGLY
Reckitt Benckiser Group Trading Down 1.1 %
Reckitt Benckiser Group Cuts Dividend
The company also recently declared a dividend, which will be paid on Monday, September 23rd. Investors of record on Monday, August 5th will be given a dividend of $0.1915 per share. The ex-dividend date of this dividend is Monday, August 5th.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Read More
- Five stocks we like better than Reckitt Benckiser Group
- How to Invest in the FAANG Stocks
- Edgewise Therapeutics Soars 50%: Key Reasons Behind the Surge
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- How the Fed’s Rate Cut Could Supercharge These 3 ETFs
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Microsoft Stock: 3 Reasons It’s Ready to Crush Q4
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.